| Initial public offerings, subscription precommitments and venture capital participation H Jeppsson Journal of Corporate Finance 50, 650-668, 2018 | 21 | 2018 |
| Leaving money on the table in venture-backed biotechnology IPOs H Jeppsson Journal of Commercial Biotechnology 22 (4), 27-38, 2016 | 2 | 2016 |
| Essays on information asymmetry, disclosures and the financing of R&D. The case of the biotechnology industry H Jeppsson | 2 | 2013 |
| Information asymmetry, R&D disclosures and the choice between private and public equity H Jeppsson University of Gothenburg, Gothenburg, Sweden, 2013 | 2 | 2013 |
| The use of valuation models by European biotechnology analysts H Jeppsson, E Holmberg rapport nr.: Master Degree Project 2009: 101, 2011 | 2 | 2011 |
| Biotech venture investments in public equities and performance H Jeppsson Journal of Commercial Biotechnology 22 (4), 39-52, 2016 | 1 | 2016 |
| Corporate takeovers, sales procedures and alliances H Jeppsson | | 2022 |
| Is there a winner's curse in the biopharmaceutical industry? H Jeppsson | | 2022 |
| Biomarker of quality? Venture‐backed biotech IPOs and insider participation H Jeppsson Journal of Applied Corporate Finance 30 (1), 78-88, 2018 | | 2018 |
